Cancer is one of the central threats to longevity. It shortens life, disrupts families, changes identity, and often appears after years of silent biological change.
For many people, the first sign of cancer is not the beginning of the disease. It is the moment the disease has finally become visible.
At HealthSpan Longevity Living, we believe cancer prevention belongs at the center of any serious longevity plan. A longevity program that does not include a disciplined cancer prevention strategy is incomplete, no matter how thoroughly the rest of the body is mapped.
Cancer prevention is not one test. It is a medical framework. It includes reducing modifiable risk, identifying inherited and acquired vulnerability, completing evidence-based screening, acting on abnormal results, and using new early detection technologies with care rather than hype.
In 2026, the American Cancer Society estimates that the United States will see 2,114,850 new cancer cases and 626,140 cancer deaths. Cancer survival has improved substantially, with five-year relative survival for all cancers combined now reaching about 70 percent for people diagnosed from 2015 through 2021. This is progress. It is also a reminder that the best cancer strategy remains prevention whenever possible, earlier detection when prevention is not possible, and careful long-term risk management over a lifetime.
Executive Summary
Cancer prevention should be viewed as a pillar of longevity medicine for four reasons.
First, a large proportion of cancer risk is influenced by modifiable factors. A 2024 American Cancer Society study estimated that about four in 10 cancer cases and about one-half of cancer deaths among U.S. adults age 30 and older were attributable to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.
Second, cancer is linked to many of the same biological pathways that drive cardiovascular disease, dementia, diabetes, kidney disease, and frailty. Visceral fat, insulin resistance, chronic inflammation, sleep disruption, tobacco exposure, alcohol use, and physical inactivity do not damage only one organ system. They affect the whole person.
Third, evidence-based cancer screening saves lives when it is done correctly and completed consistently. Screening is designed to find cancer before symptoms appear, and in the case of colorectal cancer, screening can also prevent cancer by identifying precancerous lesions before they become invasive. The CDC emphasizes regular screening for breast, cervical, colorectal, and lung cancers before symptoms appear.
Fourth, new technologies such as multi-cancer early detection blood tests are promising, but they require careful interpretation. Some of these tests are commercially available, but they are not yet FDA-approved for routine population screening, and they should not replace established screening tests.
The HLL approach is neither passive nor reckless. We do not wait for symptoms, but we also do not confuse novelty with certainty. We build a cancer prevention plan that is personal, evidence-based, medically supervised, and continuously updated.
Cancer Often Begins Long Before It Is Diagnosed
Cancer is not a single disease. It is a family of diseases characterized by abnormal cell growth, genetic change, immune escape, invasion, and in some cases metastatic spread. Some cancers evolve slowly over many years. Others behave aggressively and become life-threatening quickly.
This is why cancer prevention has to be more than a yearly reminder to stay up to date. A serious cancer prevention plan asks deeper questions.
- What is this person’s inherited risk?
- What is their metabolic risk?
- What is their inflammatory burden?
- What is their exposure history?
- What screening has been completed?
- What screening has been missed?
- What abnormal results were never followed to completion?
- What emerging tests may be reasonable, and what are their limitations?
At HLL, we treat cancer prevention as a longitudinal medical process. The goal is to reduce risk before cancer forms, detect disease earlier when risk cannot be eliminated, and avoid both complacency and overtesting.
The Modifiable Cancer Risk Conversation
Many cancers are not fully preventable. Genetics, aging, random DNA replication errors, environmental exposures, and chance all play a role. Still, it is medically inaccurate to treat cancer as if it is entirely unpredictable.
The American Cancer Society’s prevention guidance focuses on body weight, physical activity, diet, and alcohol use because these factors are among the most important modifiable determinants of cancer risk for people who do not use tobacco. The ACS recommends maintaining a healthy body weight throughout life, being physically active, following a healthy eating pattern, and avoiding or limiting alcohol.
For HLL, this creates a direct link between cancer prevention and our broader longevity model. Cancer prevention overlaps with vascular health, brain health, metabolic health, kidney health, and functional longevity.
A well-built cancer prevention plan should address at least eight domains.
1. Tobacco exposure: still the dominant preventable cancer risk
Tobacco remains one of the most important cancer prevention issues in medicine. Smoking causes cancer and also interferes with the body’s ability to fight cancer. The CDC states plainly that if a person does not use tobacco, they should not start, and if they do use tobacco, they should quit. Quitting can reduce the risk of cancer and other chronic diseases, regardless of how long someone has smoked.
In a longevity practice, tobacco history should be documented with precision.
- Current or former smoking
- Pack-years
- Time since quitting
- Cigar, pipe, vaping, or smokeless tobacco use
- Secondhand smoke exposure
- Prior cessation attempts
- Readiness to quit
- Eligibility for lung cancer screening
For patients with a meaningful smoking history, the cancer conversation must include lung cancer screening when appropriate, but it should not stop there. Tobacco also increases risk for cancers of the mouth, throat, esophagus, bladder, pancreas, kidney, cervix, stomach, colon, rectum, liver, and acute myeloid leukemia.
Tobacco cessation is not simply a lifestyle suggestion. It is cancer prevention, cardiovascular prevention, pulmonary prevention, and longevity medicine.
2. Alcohol: the cancer risk many health-conscious people underestimate
Alcohol occupies a strange place in modern health culture. It is socially accepted, commercially celebrated, and often minimized in conversations about prevention. Yet the cancer data are clear enough that the U.S. Surgeon General issued a 2025 advisory describing a causal link between alcohol consumption and increased risk of at least seven cancers: breast cancer in women, colorectal cancer, esophageal cancer, liver cancer, mouth cancer, throat cancer, and laryngeal cancer.
The American Cancer Society states that, for cancer prevention, it is best not to drink alcohol. For those who do drink, ACS advises limiting intake to no more than two drinks per day for men and one drink per day for women.
This is an important HLL topic because many successful, educated, health-conscious adults are doing several things right. They exercise, take supplements, monitor labs, and undergo executive physicals. Yet they may still drink wine, cocktails, or spirits several nights per week without realizing that alcohol is not metabolically neutral and not cancer-neutral.
The HLL message should be direct but not moralistic.
The HLL Cancer Prevention Framework
At HealthSpan Longevity Living, cancer prevention is organized into a structured clinical pathway.
Step 1: Personal risk inventory
We begin with a careful history.
- Age and sex
- Family history of cancer
- Prior cancer or precancerous lesions
- Genetic testing history
- Tobacco history
- Alcohol use
- Body composition and metabolic risk
- Physical activity
- Diet pattern
- Sleep and sleep apnea risk
- Occupational and environmental exposures
- Sun exposure history
- Vaccine history
- Screening history
- Missed follow-up or unresolved abnormal results
Many cancer prevention failures occur because no one has taken the time to build the complete map.
Step 2: Modifiable risk reduction
The prevention plan should address tobacco cessation, alcohol reduction, weight and visceral fat reduction, insulin resistance, exercise prescription, nutrition quality, sleep optimization, vaccination, sun protection, and follow-up of abnormal findings.
This must be individualized. A 42-year-old woman with dense breasts, family history, alcohol use, and insulin resistance needs a different plan from a 68-year-old former smoker with coronary artery disease and a 40 pack-year history.
Step 3: Evidence-based screening
Screening should be age-appropriate, risk-adjusted, and tracked.
A serious program does not merely advise patients to see your doctor for screening. It documents what is due, what has been done, what was abnormal, and what needs follow-up.
Step 4: Advanced risk discussion
Some patients may benefit from additional consideration of genetic counseling, germline testing, breast MRI or supplemental breast imaging, lung cancer screening beyond simple history review, dermatology referral for high-risk skin surveillance, gastroenterology surveillance based on prior polyps, MCED blood testing with informed consent, and targeted imaging when clinically justified.
Advanced does not mean indiscriminate. Better testing is better than more testing.
Step 5: Longitudinal follow-up
Cancer prevention is not a one-day executive physical. It is a living plan.
The plan must be updated as the patient ages, as family history changes, as guidelines evolve, as new symptoms appear, as new tests emerge, and as prior results require surveillance.
This is where HLL distinguishes itself. We do not simply generate data. We interpret it, act on it, and follow it over time.
CANCER PREVENTION AND THE MEANING OF LONGEVITY
Longevity medicine is often marketed through biological age tests, supplements, hormone optimization, and performance metrics. Some of these tools may have a place. The foundation of longevity remains more serious than that.
A person who avoids a preventable cancer gains more than years. They preserve independence, memory, relationships, productivity, and peace. A person whose cancer is detected at an earlier and more treatable stage may avoid the suffering that comes with advanced disease. A family spared a late diagnosis is spared a trauma that statistics cannot fully capture.
This is why cancer prevention belongs in the same conversation as blood pressure, ApoB, coronary calcium, insulin resistance, VO2 max, dementia prevention, and kidney function. These are not separate conversations. They are different windows into the same question.
How do we protect the human being before disease takes command?
HLL POSITION STATEMENT
At HealthSpan Longevity Living, we believe cancer prevention is longevity medicine.
We believe a serious prevention plan should reduce modifiable risk, complete evidence-based screening, identify inherited and acquired vulnerability, use emerging technology responsibly, and follow abnormal findings until there is a clear answer.
We believe early detection should be pursued with intelligence, not fear.
We believe patients deserve more than a generic annual physical and a checklist. They deserve a physician-led strategy that sees the whole person, the whole risk profile, and the long arc of health.
Cancer prevention is not a guarantee. Medicine rarely offers guarantees. It is one of the most meaningful ways to change the trajectory of a life.
The best time to build a cancer prevention plan is before symptoms appear.
That is the work of longevity medicine.
That is the work of HealthSpan Longevity Living.
The HLL founding cohort is now opening in Atlanta.
For individuals who want a more precise, prevention-focused approach to cancer risk, information and registration are available at:
healthspanlongevityliving.com/launch-waitlist-2026
DISCLAIMER
This brief is intended for educational purposes. It does not establish a physician-patient relationship and is not a substitute for individualized medical advice. Recommendations should be reviewed and adapted in the context of a patient’s complete history, examination, and clinical judgment by a qualified physician.
SELECTED REFERENCES
- American Cancer Society. Cancer Facts and Figures 2026. Atlanta: American Cancer Society; 2026.
- American Cancer Society. New ACS study: four in 10 cancer cases and about one-half of cancer deaths in U.S. adults age 30 and older are attributable to modifiable risk factors. Press release, July 11, 2024.
- Centers for Disease Control and Prevention. Cancer Screening Tests. CDC.
- U.S. Department of Health and Human Services, Office of the Surgeon General. Alcohol and Cancer Risk: The U.S. Surgeon General’s Advisory. 2025.
- American Cancer Society. American Cancer Society Guideline for Diet and Physical Activity for Cancer Prevention. CA Cancer J Clin. 2020;70(4):245-271.
- U.S. Food and Drug Administration. Important Information: Final Rule to Amend the Mammography Quality Standards Act. Enforcement of updated MQSA regulations, including breast density notification requirements, began September 10, 2024.
- U.S. Preventive Services Task Force. Breast Cancer: Screening. Recommendation for biennial screening mammography for women ages 40 to 74 years.
- U.S. Preventive Services Task Force. Colorectal Cancer: Screening. Recommendation for adults ages 45 to 75 years, with selective screening for adults ages 76 to 85 years.
- Centers for Disease Control and Prevention. Screening for Lung Cancer. Summary of USPSTF recommendation for yearly low-dose CT in adults ages 50 to 80 with a 20 pack-year or greater smoking history.
- Centers for Disease Control and Prevention. Vaccines and Cancer Prevention. HPV vaccination prevents several cancers; hepatitis B vaccination helps prevent liver cancer.
- American Cancer Society. Multi-cancer Detection Tests. MCED tests look for signs of multiple cancers from a single blood sample, but are not yet FDA-approved, although some are commercially available.
- International Agency for Research on Cancer. IARC Monographs evaluate consumption of red meat and processed meat. Processed meat classified as carcinogenic to humans; red meat classified as probably carcinogenic to humans. [VERIFY against the original IARC monograph before final publication.]
